Results 131 to 140 of about 8,110,219 (215)

Myelin-Associated Glycoprotein Antibody [PDF]

, 2020
openaire   +1 more source

Paramagnetic Rim Lesions Are Associated With Trans‐Synaptic Degeneration of the Visual Pathway in Multiple Sclerosis

Annals of Clinical and Translational Neurology, Volume 13, Issue 9, Page 1831-1841, September 2026.
ABSTRACT Objectives Retrograde trans‐synaptic degeneration (rTSD) from posterior visual pathway lesions in multiple sclerosis (MS) is characterized by hemi‐macular ganglion cell‐inner plexiform layer (GCIPL) thinning and contralateral visual field loss.
Abdul Jaber Tayem, Angel Liu, Sargis Manukyan, Mustafa Subhi, Elaina Luskin, Bryan Quah, Sreekanth Madhusoodhanan Nair, Arzu C. Has Silemek, Gabriela Zabala, Yujie Cui, Laura Locke, Paula Barreras, Marwa Kaisey, Vinicius Calsavara, Daniel S. Reich, Nancy L. Sicotte, Pascal Sati, Omar Al‐Louzi   +17 more
wiley   +1 more source

Editorial: Myelin-Mediated Inhibition of Axonal Regeneration: Past, Present, and Future

Frontiers in Molecular Neuroscience, 2017
Wilfredo Mellado, Sari Hannila
doaj   +1 more source

Proinflammatory Epstein–Barr Virus Antibody Functions Track with Disease Activity in Multiple Sclerosis

Annals of Neurology, Volume 100, Issue 3, Page 547-558, September 2026.
Objective Epstein–Barr virus (EBV) has been implicated in the pathogenesis of multiple sclerosis (MS). Elevated immunoglobulin G (IgG) titers against EBV nuclear antigen 1 (EBNA1) represent the most consistent serological marker of MS risk, with levels remaining persistently elevated following disease onset.
Malina Behrens, Paula Terroba‐Navajas, Eline A.J. Willemse, Sabine Schädelin, Manuel Comabella, Christian Münz, Gordan Lauc, Yannic Bartsch, Jens Kuhle, Jan D. Lünemann   +9 more
wiley   +1 more source

A Phase Ib Case Series Using Bortezomib With Chemotherapy in Atypical Teratoid/Rhabdoid Tumors

Cancer Medicine, Volume 15, Issue 9, September 2026.
ABSTRACT Background Atypical teratoid/rhabdoid tumors (ATRTs) are aggressive pediatric brain tumors that are sensitive to proteasome inhibitors in preclinical models. We evaluated the feasibility of combining the proteasome inhibitor, bortezomib, with chemotherapy.
Wan‐Ling Ho, Ming‐Yun Hsieh, Yu‐Mei Liao, Shyh‐Shin Chiou, Her‐Shyong Shiah, Chang‐Hsu Chiang, Shiann‐Tarng Jou, Hsiu‐Ju Yen, Yi‐Yen Lee, Muh‐Lii Liang, Ting‐Chi Yeh, Yu‐Cheng Chou, Fang‐Liang Huang, Shu‐Huey Chen, Hsin‐Lun Lee, Chia‐Chun Kuo, Yi‐Shan Yang, Shu‐Mei Chen, Min‐Lan Tsai, Hsi Chang, Kevin Li‐Chun Hsieh, Chia‐Lang Fang, Chia‐Yau Chang, Jinn‐Li Wang, Chu‐Chin Chen, Joon‐Khim Loh, Pei‐Chin Lin, Tzu‐Chin Lin, Shih‐Chung Wang, Yi‐Fang Tu, Chao‐Neng Cheng, Jimmy Ming‐Jung Chuang, Huy Minh Tran, Shian‐Ying Sung, Irving Lai, Kuo‐Sheng Wu, James S. Miser, Yen‐Lin Liu, Tai‐Tong Wong   +38 more
wiley   +1 more source

Myelin oligodendrocyte glycoprotein associated disease

Journal of Clinical Ophthalmology and Research
Nikhat Iqbal Tamboli, Asma Farheen, Snehalata Yellambkar, Rajesh Subhash Joshi   +3 more
doaj   +1 more source

Persistent Post‐Traumatic Brain Injury Hiccups Unresponsive to Standard Agents: Resolution Associated With Levetiracetam Therapy

Clinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Post‐traumatic hiccups are an uncommon but distressing complication of traumatic brain injury (TBI), often resistant to conventional pharmacological agents, and the underlying mechanism may involve central neurological disruption of inhibitory pathways rather than gastrointestinal or metabolic aetiologies. We report a male patient in his early
Rostom Karajeh, Ranya Abu Khalaf, Mostafa Ibraheem Abo Alrob, Saif Khaled Abdalhadi Azzam, Youssef Abdelqader Alsaeed   +4 more
wiley   +1 more source

Anaesthetic concerns in pregnancy associated with myelin oligodendrocyte glycoprotein encephalomyelitis

Indian Journal of Anaesthesia, 2022
Aswini Kuberan, Rajasekar Ramadurai, Mukilan Balasubramanian, Ankita Dey   +3 more
doaj   +1 more source

Anti‐TNF‐Alpha Associated Central Nervous System Demyelination. Drug‐Induced Demyelination or Multiple Sclerosis Trigger? A Case Series

Clinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Adalimumab is a monoclonal antibody that targets TNF‐α and is effective in treating several autoimmune disorders, including non‐infectious uveitis; however, it has been associated with demyelinating lesions. This study presents two cases of CNS demyelination in patients who consumed adalimumab. First, an 18‐year‐old man presented with subacute
Marzie Abutorabi‐zarchi, Amin Ziyaei, Davoud Ghane   +2 more
wiley   +1 more source

Recent Advancements in Drug Delivery Across the Blood–Brain Barrier in Amyotrophic Lateral Sclerosis (ALS)

CNS Neuroscience &Therapeutics, Volume 32, Issue 9, September 2026.
Progressive BBB/BSCB dysfunction is increasingly recognized as both a pathological feature and a therapeutic barrier in ALS. Novel delivery technologies and barrier‐restoration strategies may enhance CNS drug exposure, improve the efficacy of disease‐modifying therapies, and advance ALS treatment. ABSTRACT Background Amyotrophic lateral sclerosis (ALS)
Nitesh Sanghai, Kaitlyn Pierce, Nidhi Sharma, Sasha Leggett, Tara Chand Yadav, Pegah Masrori, Devi Atukorallaya, Senthilnathan Palaniyandi, Paul C. Marcogliese, Geoffrey K. Tranmer   +9 more
wiley   +1 more source